| Primary |
| Nephrogenic Anaemia |
66.7% |
| Product Used For Unknown Indication |
26.7% |
| Hepatitis C |
6.7% |
|
| Death |
28.6% |
| Aplasia Pure Red Cell |
7.1% |
| Cardiac Disorder |
7.1% |
| Disease Progression |
7.1% |
| Local Swelling |
7.1% |
| Lymphadenopathy |
7.1% |
| Post Procedural Haemorrhage |
7.1% |
| Renal Failure Chronic |
7.1% |
| Sepsis |
7.1% |
| Thrombocytopenia |
7.1% |
| Ventricular Tachycardia |
7.1% |
|
| Secondary |
| Nephrogenic Anaemia |
53.9% |
| Product Used For Unknown Indication |
16.4% |
| Hepatitis C |
5.2% |
| Anaemia |
4.3% |
| Aplasia Pure Red Cell |
3.4% |
| Dialysis |
3.0% |
| Drug Use For Unknown Indication |
3.0% |
| Cryoglobulinaemia |
2.6% |
| Neutropenia |
1.3% |
| Renal Failure Chronic |
1.3% |
| Breast Cancer |
0.9% |
| Hypertension |
0.9% |
| Immune System Disorder |
0.9% |
| Pancreas Transplant |
0.9% |
| Renal Transplant |
0.9% |
| Blood Pressure |
0.4% |
| Haemoglobin Decreased |
0.4% |
| Hypovitaminosis |
0.4% |
|
| Death |
21.6% |
| Aplasia Pure Red Cell |
17.2% |
| Haemoglobin Decreased |
8.6% |
| Anaemia |
6.0% |
| Renal Failure Chronic |
6.0% |
| Therapeutic Response Decreased |
6.0% |
| Septic Shock |
5.2% |
| Anaemia Haemolytic Autoimmune |
3.4% |
| Infection |
3.4% |
| Myocardial Infarction |
3.4% |
| Haemorrhoidal Haemorrhage |
2.6% |
| Sepsis |
2.6% |
| Local Swelling |
1.7% |
| No Therapeutic Response |
1.7% |
| Pancytopenia |
1.7% |
| Post Procedural Haemorrhage |
1.7% |
| Small Intestinal Haemorrhage |
1.7% |
| Sudden Hearing Loss |
1.7% |
| Transplant Rejection |
1.7% |
| Tuberculosis |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.0% |
| Product Used For Unknown Indication |
22.0% |
| Peritoneal Dialysis |
5.3% |
| Pancytopenia |
4.8% |
| Anaemia |
4.1% |
| Multiple Myeloma |
3.9% |
| Neutropenia |
3.6% |
| Back Pain |
2.9% |
| Hepatitis C |
2.9% |
| Renal Failure Chronic |
2.9% |
| Hypertension |
2.4% |
| Urinary Tract Infection |
2.4% |
| Prophylaxis |
2.2% |
| Renal Transplant |
2.2% |
| Nephrogenic Anaemia |
1.9% |
| Venous Thrombosis |
1.5% |
| Pain |
1.2% |
| Hyperparathyroidism Secondary |
1.0% |
| Nausea |
1.0% |
| Anaesthesia |
0.7% |
|
| Death |
14.8% |
| Acute Myeloid Leukaemia |
9.8% |
| Liver Disorder |
6.6% |
| Hepatic Necrosis |
4.9% |
| Leukopenia |
4.9% |
| Localised Oedema |
4.9% |
| Myocardial Ischaemia |
4.9% |
| Pancreatic Enzymes Increased |
4.9% |
| Respiratory Failure |
4.9% |
| Septic Shock |
4.9% |
| Vasculitis |
4.9% |
| Anaphylactic Shock |
3.3% |
| Cardiac Arrest |
3.3% |
| Complications Of Transplanted Kidney |
3.3% |
| Diarrhoea |
3.3% |
| Dyspnoea |
3.3% |
| Epilepsy |
3.3% |
| Hepatocellular Injury |
3.3% |
| Incorrect Dose Administered |
3.3% |
| Pneumonia Fungal |
3.3% |
|
